Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 1999

View Archived Issues

Company Profile: DeveloGen

Efficacy of FXR-targeting therapy validated by Symphar-Ilex team

Faulding acquires anxiety drug from American Home Products

Positive phase III trial results for OraPharma's periodontal disease treatment

Cambridge NeuroScience allowed two U.S. patents for GGF2

Elan to acquire Neuralab and Axogen

YM-68128: orally active double prodrug of a potent antiplatelet agent

Sankyo presents new antifungal agent at Japanese symposium

Team from P&G discovers new use for an old drug

NMDA antagonists reported to be useful for IBS

MMP inhibitor NF-681 targets renal cell carcinoma

Combinations of imidazoles for female genital infections

Eisai and partner launch Aricept in Japan

Toyama describes quinolones with particularly high potency against P. acnes

Indoles from Fujisawa exert both hypoglycemic and PDE-inhibitory effects

MMP inhibitors in early development at Sankyo

Potent platelet aggregation inhibitors claimed by Meiji Seika

Shionogi scientists design new series of HIV integrase inhibitors

1999 ACAAI news: SC-236 modulates histamine release in in vitro model of allergy

rhuMAb-E25 may be safely administered during a second pollen season

Gilead initiates multinational phase III trial of once-daily oral HIV treatment

First report of efficacy of an antihistamine in vasomotor rhinitis presented at ACAAI meeting

Eukarion awarded SBIR grant to develop treatment for radiation damage

Clinical trials commence with T-20 in pediatric HIV infection

Potent, selective, orally active and nonulcerogenic COX-2 inhibitor identified at Merck Frosst

SoRI-9409, a potent antinociceptive agent with promising advantages

Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo

Interim results from phase II trial of Neotrofin in AD demonstrate safety and effects on memory

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...